Communications orales et posters
oral (34 documents )
Alpha-synuclein in the enteric nervous system: a predictive marker of PD?Pascal Derkinderenabstract : oralTowards neuroprotective / translational strategies: Potential biomarkerssciencesconf.org:hope2018:178882
|
Alpha-synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreadingChiara Zurzoloabstract : oralPathophysiology explored in cellular and animal models - Alpha-synuclein, propagation sciencesconf.org:hope2018:178855
|
Causes and prevention of progressive locomotor disruption in a Drosophila model of Parkinson's diseaseSerge Birmanabstract : oralPathophysiology explored in cellular and animal models : Drosophila modelssciencesconf.org:hope2018:178872
|
Deep brain stimulation for Parkinson's diseaseMarie-Laure Welterabstract : oralHuman PD Pathophysiology - Brain imaging and therapeutic approach in clinicsciencesconf.org:hope2018:207668
|
Deregulated pathways in PD TranscriptomeMarie-Christine Chartier-Harlinabstract : oralHuman PD Pathophysiology - Genetics/Epigenetics/Gene-environment in PDsciencesconf.org:hope2018:178842
|
Does the stress protein TP53INP1 limit dopamine neuron death associated with normal ageing and Parkinson's disease ?Emilie Dinh, Christophe Melon, Pascal Salin, Sylviane Lortet, Alice Carrier, Lydia Kerkerian-Le-Goffabstract : oralPrésentations de juniors sélectionnéessciencesconf.org:hope2018:198217
|
Epigenetics, plasticity and neurodegenerative disorderAnne-Laurence Boutillierabstract : oralHuman PD Pathophysiology - Genetics/Epigenetics/Gene-environment in PDsciencesconf.org:hope2018:178841
|
Functional interactions between alpha-synuclein and LRRK2Emmanuel Brouilletabstract : oralPathophysiology explored in cellular and animal models - Modeling including other genetic factorssciencesconf.org:hope2018:178857
|
Gating of basal ganglia functions by striatal cholinergic interneurons in experimental parkinsonismCorinne Beurrier, Nicolas Mauriceabstract : oralPathophysiology explored in cellular and animal models - Modeling including other genetic factors (2)sciencesconf.org:hope2018:178866
|
Gene-Environment interactions in Parkinson's diseaseAlexis Elbazabstract : oralHuman PD Pathophysiology - Genetics/Epigenetics/Gene-environment in PDsciencesconf.org:hope2018:178846
|
Genetics as an entrypoint for personalized medicine approaches in Parkinson's diseaseRejko Krügerabstract : oralTowards neuroprotective / translational strategies: New tools for the cellular modelingsciencesconf.org:hope2018:178875
|
Human iPSC and microfluidics to model α-synuclein propagation in neuronal networksSimona Gribaudoabstract : oralTowards neuroprotective / translational strategies: New tools for the cellular modelingsciencesconf.org:hope2018:178876
|
Identification of potential new genes involved in autosomal recessive forms of Parkinson's diseaseChristelle Tesson, Aurélie Honoré, Valérie Drouet, Suzanne Lesage, Alexis Briceabstract : oralHuman PD Pathophysiology - Genetics/Epigenetics/Gene-environment in PDsciencesconf.org:hope2018:178840
|
Impact of Parkin deficiency on inflammation in PDFrançois Mouton-Ligerabstract : oralPathophysiology explored in cellular and animal models : Neuroinflammation and immune systemsciencesconf.org:hope2018:178874
|
Inhibition of glucocerebrosidase activity in a transgenic mice overexpressing alpha-synucleinElodie Cuvelier, William Sibran, Hélène Carrié, Cécile Phan, Coline Leghay, Johanna von Gerichten, Roger Sandhoff, Viola Nordström, Thomas Comptdaer, Pierre Semaille, Nathalie Jouy, Charlotte Laloux, Jean-François Goossens, Claire Pinçon, Christel Vanbesien-Mailliot, Bernard Gressier, Alain Destée, Marie-Christine Chartier-Harlin, Karim Belarbiabstract : oralPrésentations de juniors sélectionnéessciencesconf.org:hope2018:207342
|
Iron as a therapeutic target for Parkinson's diseaseDavid Devosabstract : oralTowards neuroprotective / translational strategies: Preclinical tools and neuroprotective strategysciencesconf.org:hope2018:178880
|
LRRK2 detection in urine exosomes as a potential biomarker of PD?Jean-Marc Taymansabstract : oralTowards neuroprotective / translational strategies: Potential biomarkerssciencesconf.org:hope2018:178881
|
Lysosomal dysfunction in PD (SNCA, ATP13A2, GBA)Benjamin Dehayabstract : oralPathophysiology explored in cellular and animal models - Modeling including other genetic factorssciencesconf.org:hope2018:178859
|
Mitophagy and beyond in autosomal recessive Parkinson's diseaseOlga Cortiabstract : oralPathophysiology explored in cellular and animal models - Modeling including other genetic factorssciencesconf.org:hope2018:207304
|
Mitophagy modulation as a potential therapeutic target for neurodegenerative diseasesHélène Plun-Favreauabstract : oralPathophysiology explored in cellular and animal models - Modeling including other genetic factors (2)sciencesconf.org:hope2018:178864
|
MRI and NMR in PD researchStéphane Lehéricyabstract : oralHuman PD Pathophysiology - Brain imaging and therapeutic approach in clinicsciencesconf.org:hope2018:178819
|
Neuro-immune interactions in Parkinson's disease: new insights from analysis of perivascular macrophage functionStéphane Hunotabstract : oralPathophysiology explored in cellular and animal models : Neuroinflammation and immune systemsciencesconf.org:hope2018:178873
|
Novel therapeutic approach for PD: gene therapyStéphane Palfiabstract : oralHuman PD Pathophysiology - Brain imaging and therapeutic approach in clinicsciencesconf.org:hope2018:178830
|
Optogenetic to regulate neuronal activity: modulation of striatal cholinergic interneurons and muscarinic receptors as targets in rodent models of Parkinson's diseaseMarianne Amalricabstract : oralPathophysiology explored in cellular and animal models - Modeling including other genetic factors (2)sciencesconf.org:hope2018:178867
|
Parkin transcription factor function in Parkinson's diseaseEric Duplanabstract : oralPathophysiology explored in cellular and animal models - Modeling including other genetic factors (2)sciencesconf.org:hope2018:178865
|
Pathobiology of LRRK2: where do we stand?Elisa Greggioabstract : oralPathophysiology explored in cellular and animal models - Modeling including other genetic factorssciencesconf.org:hope2018:178858
|
PET Imaging of PD patientsPhilippe Rémyabstract : oralHuman PD Pathophysiology - Brain imaging and therapeutic approach in clinicsciencesconf.org:hope2018:178820
|
Prediction of PD progression and response to treatmentJean-Christophe Corvolabstract : oralTowards neuroprotective / translational strategies: Potential biomarkerssciencesconf.org:hope2018:178883
|
Prion-like dissemination of synuclein pathology using human brain-derived alpha-synuclein in mice and monkeysErwan Bézardabstract : oralPathophysiology explored in cellular and animal models - Alpha-synuclein, propagation sciencesconf.org:hope2018:178856
|
Ret protects the midbrain dopaminergic system against α-synuclein toxicityEdgar Kramerabstract : oralTowards neuroprotective / translational strategies: Preclinical tools and neuroprotective strategysciencesconf.org:hope2018:178877
|
Role of LRRK2 in mitochondrial function in Parkinson's disease: Focus on PINK1/Parkin-dependent mitophagyFiona Bonello, Sidi-Mohamed Hassoun, Francois Mouton Liger, Alexis Brice, Florence Cormier, Suzanne Lesage, Jean-Christophe Corvol, Olga Cortiabstract : oralPrésentations de juniors sélectionnéessciencesconf.org:hope2018:203299
|
Structural, physical and functional properties of alpha-synuclein fibrils and their propagations in synucleinopathiesRonald Melkiabstract : oralPathophysiology explored in cellular and animal models - Alpha-synuclein, propagation sciencesconf.org:hope2018:178851
|
The role of mitochondrial calcium in PINK1/Parkin related Parkinson's diseaseAlex Whitworthabstract : oralPathophysiology explored in cellular and animal models : Drosophila modelssciencesconf.org:hope2018:178871
|
Validation of protein phosphatases that regulate the LRRK2 phosphorylation cycleMatthieu Drouyer, Marco Emanuele, Réginald Lefebvre, Katia Maggio, Alain Martoriati, Thomas Comptdaer, Pierre Semaille, William Sibran, Evy Lobbestael, Marc Bolliger, Veerle Baekelandt, Jeremy Nichols, Marie-Christine Chartier-Harlin, Jean-Marc Taymansabstract : oralPrésentations de juniors sélectionnéessciencesconf.org:hope2018:207515
|
poster (8 documents )
Alpha-synuclein and LRRK2's cooperation in mitochondrial dysfunctions in Parkinson's DiseaseCamille Gardier, Noémie Cresto, Marie-Claude Gaillard, Noëlle Dufour, Alexis Bemelmans, Emmanuel Brouillet, Géraldine Liotabstract : posterPrésentations de juniors sélectionnéessciencesconf.org:hope2018:199327
|
An injectable Collagen Hydrogel as a delivery system for Parkinson's diseaseFrancesco Gubinelli, Silvia Cabré Giménez, Veronica Alamilla Marroquin, Eilis Dowd, Emmanuel Brouillet, Julien Flamentabstract : posterPrésentations de juniors sélectionnéessciencesconf.org:hope2018:202297
|
Characterisation of two genetic rat models of Parkinson Disease through two presynaptic PET tracers; [18F]-LBT999 and 6-[18F]fluoro-L-m-tyrosinePauline Roost, Mylène Gaudin, Martine Guillermier, Francesco Gubinelli, Noémie Cresto, Leopold Eymin, Charlène Josephine, Marie-Claude Gaillard, Alexis Bemelmans, Yann Bramoullé, Emmanuel Brouillet, Philippe Hantraye, Nadja Van Campabstract : posterPrésentations de juniors sélectionnéessciencesconf.org:hope2018:202811
|
Does the stress protein TP53INP1 limit dopamine neuron death associated with normal ageing and Parkinson's disease ?Emilie Dinh, Christophe Melon, Pascal Salin, Sylviane Lortet, Alice Carrier, Lydia Kerkerian-Le-Goffabstract : posterPrésentations de juniors sélectionnéessciencesconf.org:hope2018:198221
|
Early serotonergic lesion promotes the emergence and severity of motor symptoms in monkeys.Mathilde Millot, Maude Beaudoin-Gobert, Sandra Duperrier, Elise Météreau, Yosuke Saga, Léon Tremblay, Véronique Sgambatoabstract : posterPrésentations de juniors sélectionnéessciencesconf.org:hope2018:202911
|
Functional imaging of parkinsonian impulse control disorders needs stronger neurocognitive footingGarance Meyer, Charlotte Spay, Bénédicte Ballanger, Philippe Boulinguezabstract : posterPrésentations de juniors sélectionnéessciencesconf.org:hope2018:202870
|
Mechanisms of neuronal death in Parkinson's disease: impact of Parkin deficiency on the mitochondrial stress response.Emeline Hamon, Maxime Jacoupy, Erpapazoglou Zoi, Alexis Brice, Olga Cortiabstract : posterPrésentations de juniors sélectionnéessciencesconf.org:hope2018:203194
|
Resting state cortical oscillatory signatures of parkinsonian impulse control disorders pinpoint motor, executive dysfunctions.Charlotte Spay, Roberto Cilia, Garance Meyer, Bénédicte Ballanger, Philippe Boulinguezabstract : posterPrésentations de juniors sélectionnéessciencesconf.org:hope2018:202873
|
|